HIFs, angiogenesis, and cancer

Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2013-05, Vol.114 (5), p.967-974
Hauptverfasser: Yang, Yongzhi, Sun, Mingjuan, Wang, Lianghua, Jiao, Binghua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 974
container_issue 5
container_start_page 967
container_title Journal of cellular biochemistry
container_volume 114
creator Yang, Yongzhi
Sun, Mingjuan
Wang, Lianghua
Jiao, Binghua
description Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc.
doi_str_mv 10.1002/jcb.24438
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1317858275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2917708271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</originalsourceid><addsrcrecordid>eNp10MtKw0AUBuBBFFurC1-gFNwoGDvXzGSpwV6k6KZYcDNMJiclNU1qpkH79qZN24UgDBwGvvNz-BG6JviBYEz7Cxs9UM6ZOkFtggPpcZ_zU9TGkmGPMkJb6MK5BcY4CBg9Ry3KKBX1a6PuaDxw9z2Tz9NiDjm4dPeLe9bkFspLdJaYzMHVfnbQdPA8DUfe5G04Dh8nnuVCKo8aAhgTAzSKrRCJAoqJr0wMsYiUtJZDrAKaMGMhCSKQSYRJwgSVQcATwjrotoldlcVXBW6tl6mzkGUmh6JymjAilVBUipre_KGLoirz-rit8gPqC8FqddcoWxbOlZDoVZkuTbnRBOttZ7ruTO86q213n1hFS4iP8lBSDfoN-E4z2PyfpF_Cp0Ok12ykbg0_xw1TfmpfMin07HWoxTvjsxBL_cF-AVHKgV4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1316926553</pqid></control><display><type>article</type><title>HIFs, angiogenesis, and cancer</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Yang, Yongzhi ; Sun, Mingjuan ; Wang, Lianghua ; Jiao, Binghua</creator><creatorcontrib>Yang, Yongzhi ; Sun, Mingjuan ; Wang, Lianghua ; Jiao, Binghua</creatorcontrib><description>Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.24438</identifier><identifier>PMID: 23225225</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>ANGIOGENESIS ; Animals ; CANCER ; Humans ; Hypoxia-Inducible Factor 1 - chemistry ; Hypoxia-Inducible Factor 1 - genetics ; Hypoxia-Inducible Factor 1 - metabolism ; HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) ; Models, Biological ; Neoplasms - blood supply ; Neoplasms - metabolism ; Neoplasms - pathology ; Neovascularization, Pathologic - metabolism ; Signal Transduction</subject><ispartof>Journal of cellular biochemistry, 2013-05, Vol.114 (5), p.967-974</ispartof><rights>Copyright © 2012 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</citedby><cites>FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.24438$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.24438$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23225225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Yongzhi</creatorcontrib><creatorcontrib>Sun, Mingjuan</creatorcontrib><creatorcontrib>Wang, Lianghua</creatorcontrib><creatorcontrib>Jiao, Binghua</creatorcontrib><title>HIFs, angiogenesis, and cancer</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc.</description><subject>ANGIOGENESIS</subject><subject>Animals</subject><subject>CANCER</subject><subject>Humans</subject><subject>Hypoxia-Inducible Factor 1 - chemistry</subject><subject>Hypoxia-Inducible Factor 1 - genetics</subject><subject>Hypoxia-Inducible Factor 1 - metabolism</subject><subject>HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1)</subject><subject>Models, Biological</subject><subject>Neoplasms - blood supply</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Signal Transduction</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtKw0AUBuBBFFurC1-gFNwoGDvXzGSpwV6k6KZYcDNMJiclNU1qpkH79qZN24UgDBwGvvNz-BG6JviBYEz7Cxs9UM6ZOkFtggPpcZ_zU9TGkmGPMkJb6MK5BcY4CBg9Ry3KKBX1a6PuaDxw9z2Tz9NiDjm4dPeLe9bkFspLdJaYzMHVfnbQdPA8DUfe5G04Dh8nnuVCKo8aAhgTAzSKrRCJAoqJr0wMsYiUtJZDrAKaMGMhCSKQSYRJwgSVQcATwjrotoldlcVXBW6tl6mzkGUmh6JymjAilVBUipre_KGLoirz-rit8gPqC8FqddcoWxbOlZDoVZkuTbnRBOttZ7ruTO86q213n1hFS4iP8lBSDfoN-E4z2PyfpF_Cp0Ok12ykbg0_xw1TfmpfMin07HWoxTvjsxBL_cF-AVHKgV4</recordid><startdate>201305</startdate><enddate>201305</enddate><creator>Yang, Yongzhi</creator><creator>Sun, Mingjuan</creator><creator>Wang, Lianghua</creator><creator>Jiao, Binghua</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201305</creationdate><title>HIFs, angiogenesis, and cancer</title><author>Yang, Yongzhi ; Sun, Mingjuan ; Wang, Lianghua ; Jiao, Binghua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>ANGIOGENESIS</topic><topic>Animals</topic><topic>CANCER</topic><topic>Humans</topic><topic>Hypoxia-Inducible Factor 1 - chemistry</topic><topic>Hypoxia-Inducible Factor 1 - genetics</topic><topic>Hypoxia-Inducible Factor 1 - metabolism</topic><topic>HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1)</topic><topic>Models, Biological</topic><topic>Neoplasms - blood supply</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Yongzhi</creatorcontrib><creatorcontrib>Sun, Mingjuan</creatorcontrib><creatorcontrib>Wang, Lianghua</creatorcontrib><creatorcontrib>Jiao, Binghua</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Yongzhi</au><au>Sun, Mingjuan</au><au>Wang, Lianghua</au><au>Jiao, Binghua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIFs, angiogenesis, and cancer</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2013-05</date><risdate>2013</risdate><volume>114</volume><issue>5</issue><spage>967</spage><epage>974</epage><pages>967-974</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>23225225</pmid><doi>10.1002/jcb.24438</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2013-05, Vol.114 (5), p.967-974
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_1317858275
source MEDLINE; Access via Wiley Online Library
subjects ANGIOGENESIS
Animals
CANCER
Humans
Hypoxia-Inducible Factor 1 - chemistry
Hypoxia-Inducible Factor 1 - genetics
Hypoxia-Inducible Factor 1 - metabolism
HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1)
Models, Biological
Neoplasms - blood supply
Neoplasms - metabolism
Neoplasms - pathology
Neovascularization, Pathologic - metabolism
Signal Transduction
title HIFs, angiogenesis, and cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A17%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIFs,%20angiogenesis,%20and%20cancer&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Yang,%20Yongzhi&rft.date=2013-05&rft.volume=114&rft.issue=5&rft.spage=967&rft.epage=974&rft.pages=967-974&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.24438&rft_dat=%3Cproquest_cross%3E2917708271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1316926553&rft_id=info:pmid/23225225&rfr_iscdi=true